2021 Japan HIV/AIDS Diagnostics Market Assessment: Supplier Shares and Segment Forecasts for HIV 1/2, Combo, Ag, NAT and Western Blot Assays

April 2021 | 60 pages | ID: 2B4226E5DA48EN
Venture Planning Group

Abstracts

This unique report from LeadingMarketResearch.com provides information and analysisnot available from any other published source.

The report is available by section, and can be customized to specific information needs and budget.

This report presents Japanese test volume and sale forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and other confirmatory assays performed in the following market segments:

• Hospitals
• Commercial/Private Labs
• Blood Banks

The DataPack also provides sales and market share estimates for major suppliers of AIDS tests, including Abbott, bioMerieux, Fujirebio, Grifols, Ortho Clinical Diagnostics/J&J, Roche, and Siemens.

Contains 60 pages and 7 tables

Contents

Major Companies Developing or Marketing AIDS Tests
Japan: HIV or HIV-1/2/Combo Test Volume and Sales Forecast by Market Segment
Japan: HIV Ag Test Volume and Sales Forecast by Market Segment
Japan: Western Blot/Other Confirmatory Tests Volume and Sales Forecast By Market Segment
Japan: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Japan: AIDS Diagnostics Market by Major Supplier
Japan: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers